MAP2K1 and cancer: Although the intracellular mediators involved in the regulation of NKG2D ligands expression are still unknown, preliminary data would indicate that the MEK1/ERK, p38 MAPK, PI3K/Akt signaling pathways are involved in MICA and MICB up-regulation in cancer [48, 49].